A guide to better pharma demand research

Discover the three essential steps for optimizing the quality and reliability of demand research.

There are more drugs in development today than ever before. At the same time, drug development costs are rising while average revenues fall. Against this turbulent backdrop, pharma companies are challenged to maximise pipeline potential while limiting financial risk. 


Demand research is fundamental to meeting this unprecedented need for guidance. However, while demand studies are powerful tools that can help companies avoid large and costly mistakes, they also have the potential to produce misleading results.


In this paper, we outline three essential steps that market researchers and pharma companies can take to avoid this danger – and, instead, optimise the quality, reliability and longevity of their demand research results:

  • Step 1: Get market representation right.
  • Step 2: Understand and address share inflation.
  • Step 3: Look at the bigger picture.

Download the white paper

More insights about Health

Related news

  • [Webinar] KEYS: Battle For Attention
    Communication Events replay

    [Webinar] KEYS: Battle For Attention

    In an era dominated by ad-skipping, multi-screening, and media fragmentation, the challenge for today’s marketer is no longer just “Who am I reaching?” but “Am I reaching them at all?"
  • Where is metabolic medicine heading
    Healthcare Events replay

    Where is metabolic medicine heading – and what do you need to know?

    What happens when pipeline promise becomes market reality? During this PBSS webinar, Scott Morano and Roberto Cortese expertly guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next.
  • KEYS: Screen time
    Media Measurement Events replay

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?